Surmodics reported $-7143000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
Align Technology ALGN:US $ 188.2M 9.89M
Anika Therapeutics ANIK:US $ -3381000 173K
Arrowhead Research ARWR:US $ -72909000 114.46M
Baxter International BAX:US $ 432M 99M
Bioscrip BIOS:US $ 59.08M 6.83M
Boston Scientific BSX:US $ 444M 337M
Cryolife CRY:US $ 1.44M 1.4M
Edap Tms EDAP:US -111000 572K
Edwards Lifesciences EW:US $ 465.6M 19.7M
Haemonetics HAE:US $ 29.48M 58M
Johnson & Johnson JNJ:US $ 6941M 599M
Merit Medical Systems MMSI:US $ 33.74M 16.84M
Mesa Laboratories MLAB:US $ -4238000 4.13M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Stryker SYK:US $ 903M 133M
Surmodics SRDX:US $ -7143000 2.24M
Trinity Biotech TRIB:US 173K 1.28M